5 Things to Know Before the Stock Market Opens
Nvidia (NVDA) shares are in investors' sights after the chipmaker's stock surged last week; Air Canada averts a shutdown with ...
Jim Cramer Says It Will Take Time For Novartis AG (NVS) To ‘Get The Attention Of Investors’
We recently compiled a list of the Top 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...
Is Novartis AG (NVS) the Best Cancer Stock to Buy Now?
In 2022, the global oncology market was valued at approximately $203.42 billion and is expected to reach over $470.61 billion ...
Top 10 Stocks on Jim Cramer’s Radar
In this article, we’ll explore the Top 10 Stocks on Jim Cramer’s Radar. Jim Cramer often reflects on how he would reform the ...
Mineralys In Hypertension: Upcoming Catalysts And Strong Positioning
Mineralys has been on the radar for some biotech investors. Read more about MLYS' hypertension treatment, upcoming trial ...
J&J mid-stage trial for lung cancer drug Rybrevant hits main goal
Phase 2 trial for lung cancer therapy Rybrevant shows significant reduction in infusion-related reactions with dexamethasone.
Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives
The urgent need for innovative technologies to accelerate the development of life-saving %Cancer therapies has never been ...
Yahoo Finance8d
0K9E.IL,0P0001JN6D,562 (0K9E.IL)
Sept. 05, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that Novartis AG (NYSE: NVS) has ...